MedXL

Name

MedXL

Legal name

MedXL Inc.

Website

https://medxl.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Medical Devices - Prefilled Syringes

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Prefilled Syringes & Safety Syringes (HLAHAIAA)

akta.pro secondary industry

Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE)

Keywords

• Prefilled syringes
• Saline flush syringes
• Sodium citrate syringes
• Automated syringe preparation
• Vascular access devices

Headquarters

HQ city

Quebec

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medical Device Manufacturing and Sales: MedXL designs and manufactures prefilled syringes and medical devices for the biomedical and pharmaceutical industries. Revenue is generated through the sale of manufactured medical devices to healthcare institutions, hospital pharmacies, and pharmaceutical companies worldwide. Products include prefilled syringes (saline, sodium citrate), diagnostic imaging accessories, IV therapy products, and pharmacy preparation devices.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

MedXL designs, manufactures and distributes prefilled syringes (saline flush syringes under the Praxiject brand and sodium citrate anticoagulant syringes under the CitraFlow and CitraFlow PLUS brands) for hospital pharmacies, dialysis centers and pharmaceutical companies. The company also produces the PraxiMed automated syringe preparation system (PraxiFill filler and PraxiLabel labeller), transfer sets, IV therapy accessories, probe covers and diagnostic imaging accessories. Manufacturing is carried out at its ISO 13485:2016- and cGMP-compliant facility in Pointe-Claire, Quebec, with combined annual capacity of over 500 million prefilled syringes following its 2024 acquisition by Amsino International.

Product overview

MedXL is a medical device manufacturer specializing in prefilled syringes and healthcare products. The core product portfolio includes Praxiject saline prefilled syringes (in Saline, SP, SF, and EP variants), CitraFlow sodium citrate prefilled syringes (4%, 30%, 46.7% concentrations), and CitraFlow PLUS combined citrate-ethanol solutions for vascular access device flushing and locking. The PraxiMed platform provides automated medication preparation through PraxiFill automated syringe filler and PraxiLabel semi-automatic syringe labeller. Additional offerings include transfer sets, pharmacy products, IV therapy accessories, probe covers, and diagnostic imaging accessories. Products feature GS1 barcode compliance at all packaging levels and color-coded identification to reduce medication errors.

Differentiator

Problem solved

Functional benefit

Brands

• Praxiject™: Brand of saline prefilled syringes for medical flushing procedures
• CitraFlow™
• PraxiMed™
• PraxiFill™
• PraxiLabel™
• PraxiFlow™
• CitraFlow PLUS™

Products and services

• Praxiject™ Saline Prefilled Syringes Pre-filled syringes containing 0.9% Sodium Chloride solution, terminally sterilized, latex-free and preservative-free, designed for flushing vascular access devices in hospital pharmacies and clinical settings.
• Praxiject™ SP Prefilled Syringes Ready-to-use sterile path saline flushing syringes offering safe and economical flushing with reliable and easy-to-use design for hospital use.
• Praxiject™ SF Prefilled Syringes Saline prefilled syringes with sterile field compatibility, latex-free and preservative-free, featuring clear concise labeling for safe and accurate use.
• CitraFlow™ 4% SF Prefilled Syringes 4% Sodium Citrate solution prefilled syringes as an alternative to heparin for locking indwelling catheters, safe for patients with Heparin Induced Thrombocytopenia.
• CitraFlow™ 30% SF Prefilled Syringes 30% Sodium Citrate anticoagulant and antimicrobial prefilled syringes for vascular access device locking, avoiding risks of systemic heparinization.
• CitraFlow™ 46.7% SF Prefilled Syringes 46.7% Sodium Citrate high-concentration anticoagulant solution for vascular access device locking, safe for patients with suspected or confirmed Heparin Induced Thrombocytopenia.
• CitraFlow PLUS™ Prefilled Syringes Combined 4% Sodium Citrate and 30% Ethanol solution in prefilled syringes, combining anticoagulant and antimicrobial properties to prevent biofilm formation and reduce catheter-related bloodstream infections (CRBSI).
• Praxiject™ EP Saline Prefilled Syringes with Enhanced Packaging Hermetically sealed enhanced packaging designed for use in kits and sets, offering stability and excellent gas barrier properties, resistant to ethylene oxide (ETO) gas sterilization.
• PraxiFlow™ Prefilled Syringe Kits Combined kits containing Praxiject saline syringes for flushing and CitraFlow sodium citrate syringes for locking vascular access devices, available in various CitraFlow concentrations (4%, 30%, 46.7%).
• PraxiMed™ System Automated medication preparation system comprising PraxiFill automated syringe filler and PraxiLabel semi-automatic syringe labeller for hospital pharmacy unit-dose syringe preparation.
• PraxiFill™ Automated Syringe Filler Automated syringe filling device designed to increase productivity by eliminating manual aspiration and capping tasks for unit-dose pharmacy-prepared syringes.
• PraxiLabel™ Semi-Automatic Syringe Labeller Semi-automatic syringe labelling device to increase labelling productivity by eliminating manual label application, compatible with standard label printers.
• Transfer Sets Multi-dosing sets including large volume parenteral administration sets, micro/mini/macro volume extension sets, and needleless technology sets and syringe infusion systems.
• Pharmacy Products Transfer sets, medication preparation sets and accessories for medication reconstitution including BCG administration kits, batching pump extension sets, and fluid collection devices.
• Intravenous Therapy Accessories Accessories for IV therapy including bidirectional valves and swabbable valves with Male/Female connectors for optimizing perfusion and protecting vascular access sites.
• Probe Covers Ultrasound probe covers in various dimensions with retractable folding design, available with elastic bands, Velcro, or gel; sterile and sterile field compatible.
• Diagnostic Imaging Accessories Accessories for diagnostic imaging including transfer spikes with swabbable valves for multi-dose applications with partial system replacement capabilities.

Quantifiable outcome

• Manufacturing capacity of over 500 million prefilled syringes annually following November 2024 acquisition by Amsino
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Amsino International Inc.coreStrategic or Co-development Partner · 25 November 2024In November 2024, Amsino International Inc., a global medical device manufacturer headquartered in Pomona, California, acquired MedXL Inc. and Liebel-Flarsheim Canada Inc., including assets and facilities in Quebec, Canada. This acquisition expands Amsino's prefilled syringe operations and increases its combined manufacturing capacity to over 500 million units annually. The deal enhances supply chain resilience in North America and minimizes customer allocation and backlog challenges.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Becton Dickinson (BD): Global medical device leader with broad prefilled syringe portfolio (BD PosiFlush, BD Heparin, BD NaCl) sold to hospital pharmacies worldwide. Directly comparable to MedXL's Praxiject saline and CitraFlow anticoagulant syringes, but operates at much larger scale across drug delivery, diagnostics, and biosciences.
• B. Braun Medical: German medical device manufacturer producing prefilled saline and heparin flush syringes (Excel, Safsite, Introcan) widely used in hospitals. Comparable to MedXL in prefilled syringe manufacturing and IV therapy accessory categories, with broader portfolio including infusion pumps and IV solutions.
• Smiths Medical (ICU Medical successor / former Smiths Group): Former division of Smiths Group producing prefilled saline syringes (Medi-Trace, Portex) and IV therapy devices for hospital and clinical markets. Comparable to MedXL in prefilled saline syringes and vascular access product categories across global hospital pharmacy channels.

Direct peers

• ICU Medical: US-listed medical device company specializing in IV therapy, including prefilled saline flush syringes and needlefree connectors closely aligned with MedXL's IV therapy accessories and saline prefilled syringe products. Sells into similar hospital pharmacy channels with comparable regulatory profile.
• West Pharmaceutical Services: Global leader in elastomer components and prefilled syringe systems (Daikyo Crystal Zenith, West Ready-to-Use syringes) serving pharmaceutical customers requiring injectable drug delivery components. Comparable to MedXL as a prefilled syringe manufacturing peer with strong regulatory expertise in drug delivery.
• Gerresheimer: European pharmaceutical packaging and prefilled syringe manufacturer producing glass syringes and injection devices for pharma companies. Comparable product overlap with MedXL in prefilled syringes for pharmaceutical customers, with stronger European footprint and primary container focus.
• Stevanato Group: Italian pharmaceutical glass manufacturer supplying prefilled syringe systems (NexaFlex, SG Alba) to pharmaceutical and biotech customers globally. Directly comparable as a prefilled syringe component manufacturer with similar positioning in injectable drug delivery packaging.
• Schott Pharma: German manufacturer of pharmaceutical primary packaging including prefilled syringes (Schott TopPac, syriQ) for drug delivery applications. Comparable to MedXL as a high-quality prefilled syringe manufacturer serving regulated injectable drug markets, listed separately from Schott AG.
• Vygon: French medical device manufacturer specializing in IV therapy, vascular access, and prefilled flush syringes (Vysafe, Vyset) sold to hospital pharmacies and neonatal units. Comparable to MedXL in prefilled flush syringes and IV accessories with overlapping European distributor networks.

Emerging players

• Amsino International: Parent company that acquired MedXL in November 2024, producing complementary prefilled syringes, IV therapy, and urology devices. Notably a related party, included for context as the strategic acquirer that defines MedXL's go-forward positioning, scale, and product roadmap.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedXL